2017
DOI: 10.1007/s11920-017-0775-9
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

Cannabis, Cannabinoids, and Sleep: a Review of the Literature

Abstract: Preliminary research into cannabis and insomnia suggests that cannabidiol (CBD) may have therapeutic potential for the treatment of insomnia. Delta-9 tetrahydrocannabinol (THC) may decrease sleep latency but could impair sleep quality long-term. Novel studies investigating cannabinoids and obstructive sleep apnea suggest that synthetic cannabinoids such as nabilone and dronabinol may have short-term benefit for sleep apnea due to their modulatory effects on serotonin-mediated apneas. CBD may hold promise for R… Show more

Search citation statements

Order By: Relevance

Paper Sections

Select...
382
69
69
2

Citation Types

14
283
3
25

Year Published

2000
2000
2026
2026

Publication Types

Select...
385
62
22
18

Relationship

2
485

Authors

Journals

citations

Cited by 470 publications

(325 citation statements)
references

References 63 publications

14
283
3
25
Order By: Relevance
“…However, it needs to be noted that all patients included in the sample had used MC for at least 1 year which may limit the possibility of detecting any development of tolerance related to length of use if this mainly occurs shortly after onset of use. Furthermore, while research has suggested that dose modulates the effect of cannabis on sleep,14 our results did not show a relationship between MC dose or potency and sleep. It needs, however, to be kept in mind that we only had a very rough measure of dose (monthly dose) and a more sensitive measure of exact dose per use session would be more informative in terms of reaching a better understanding of the association between different MC dosages and sleep problems.…”
Section: Discussioncontrasting
confidence: 99%
Exaggerated anticipatory anxiety is common in social anxiety disorder (SAD). Neuroimaging studies have revealed altered neural activity in response to social stimuli in SAD, but fewer studies have examined neural activity during anticipation of feared social stimuli in SAD. The current study examined the time course and magnitude of activity in threat processing brain regions during speech anticipation in socially anxious individuals and healthy controls (HC). Method Participants (SAD n = 58; HC n = 16) underwent functional magnetic resonance imaging (fMRI) during which they completed a 90s control anticipation task and 90s speech anticipation task.
“…However, it needs to be noted that all patients included in the sample had used MC for at least 1 year which may limit the possibility of detecting any development of tolerance related to length of use if this mainly occurs shortly after onset of use. Furthermore, while research has suggested that dose modulates the effect of cannabis on sleep,14 our results did not show a relationship between MC dose or potency and sleep. It needs, however, to be kept in mind that we only had a very rough measure of dose (monthly dose) and a more sensitive measure of exact dose per use session would be more informative in terms of reaching a better understanding of the association between different MC dosages and sleep problems.…”
Section: Discussioncontrasting
confidence: 99%
Exaggerated anticipatory anxiety is common in social anxiety disorder (SAD). Neuroimaging studies have revealed altered neural activity in response to social stimuli in SAD, but fewer studies have examined neural activity during anticipation of feared social stimuli in SAD. The current study examined the time course and magnitude of activity in threat processing brain regions during speech anticipation in socially anxious individuals and healthy controls (HC). Method Participants (SAD n = 58; HC n = 16) underwent functional magnetic resonance imaging (fMRI) during which they completed a 90s control anticipation task and 90s speech anticipation task.
“…In this study, cessation of ACPA administration to mice resulted in withdrawal symptoms such as increased rearing and decreased rubbing, consistent with previous studies 22‐24,32,33 . CWS has been reported to cause sleep disturbances in humans 1,8,14 . In the present study, ACPA‐induced withdrawal caused sleep disturbances in mice.…”
Section: Discussionsupporting
confidence: 92%
Exaggerated anticipatory anxiety is common in social anxiety disorder (SAD). Neuroimaging studies have revealed altered neural activity in response to social stimuli in SAD, but fewer studies have examined neural activity during anticipation of feared social stimuli in SAD. The current study examined the time course and magnitude of activity in threat processing brain regions during speech anticipation in socially anxious individuals and healthy controls (HC). Method Participants (SAD n = 58; HC n = 16) underwent functional magnetic resonance imaging (fMRI) during which they completed a 90s control anticipation task and 90s speech anticipation task.
“…Notably, the mean difference in the PSQI score decreased more in the treatment group than in the placebo group ( p = 0.09). This suggests a potential benefit of cannabis oil, which is consistent with prior reports of improved sleep outcomes with cannabinoids [ 12 ]. However, the lack of statistical significance in our study might have been influenced by the small sample size, which reduces the power to detect meaningful differences.…”
Section: Discussionsupporting
confidence: 89%
Exaggerated anticipatory anxiety is common in social anxiety disorder (SAD). Neuroimaging studies have revealed altered neural activity in response to social stimuli in SAD, but fewer studies have examined neural activity during anticipation of feared social stimuli in SAD. The current study examined the time course and magnitude of activity in threat processing brain regions during speech anticipation in socially anxious individuals and healthy controls (HC). Method Participants (SAD n = 58; HC n = 16) underwent functional magnetic resonance imaging (fMRI) during which they completed a 90s control anticipation task and 90s speech anticipation task.